Target intelligence / Profile preview

Paraneoplastic antigen Ma6E (PNMA6E)

Target
PNMA6E
Molecular classification
Other (Paraneoplastic Ma antigen family), Domesticated retroelement/gag-like protein family
01

Overview

Paraneoplastic antigen Ma6E (PNMA6E) is a member of the PNMA (paraneoplastic Ma antigen) gene family, which consists of proteins derived from domesticated retroelements displaying structural similarities to viral gag proteins. PNMA6E is a protein-coding gene located on the X chromosome and is expressed primarily in the male reproductive tract. Its precise physiological role is not clearly established, although suggested functions include involvement in spermatogenesis and germ cell differentiation. While other PNMA family members (such as PNMA2) are implicated in paraneoplastic neurological syndromes and can assemble into capsid-like structures, there is no direct evidence that PNMA6E itself acts as a disease antigen or forms such structures. There are no current drugs or therapeutic approaches targeting PNMA6E, nor is it an established biomarker or safety concern in human disease. Summary of Key Points: PNMA6E is a poorly characterized member of the PNMA family, structurally related to retrotransposons but not currently known as a therapeutic target or disease driver. It is not directly implicated in known diseases or targeted by any drugs. Current knowledge is limited to gene expression data and broad family homology.

Other names
PNMA family member 6EParaneoplastic antigen Ma6EPNMA6EPutative paraneoplastic antigen-like protein 6B-likeParaneoplastic Ma antigen family member 6E
02

Biological functions

Putative involvement in spermatogenesis and germ cell differentiation (based on reported expression patterns, though not yet functionally validated)Other (exact biological functions remain largely uncharacterized)
03

Disease associations

Other (No direct disease or paraneoplastic syndrome association described for PNMA6E itself; related family members are implicated in paraneoplastic neurological syndromes, but not specifically PNMA6E)

Beyond the preview

Go deeper on Paraneoplastic antigen Ma6E (PNMA6E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paraneoplastic antigen Ma6E (PNMA6E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call